Nursing care
Lactulose: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Lactulose is a synthetic sugar used as a laxative and, at higher doses, to treat hepatic encephalopathy by trapping ammonia in the gut for excretion. Soft, frequent stools are the therapeutic goal in encephalopathy dosing, so holding the drug because the patient has diarrhoea is usually the wrong call and should prompt a dose review, not automatic omission.
What it does and why it is prescribed
Lactulose is a non-absorbable disaccharide. Gut bacteria ferment it into lactic and acetic acid, which acidifies the colon. That osmotic effect draws water into the bowel and softens stool, which is why low-dose lactulose is a standard laxative for constipation and for straining that needs to be avoided, such as after certain cardiac or ocular procedures.
At the higher doses used for hepatic encephalopathy, the acidified colon converts ammonia (NH3) into ammonium (NH4+), a form that cannot cross the gut wall back into the bloodstream. The ammonium is then trapped and excreted in the stool. This is a different therapeutic target from the laxative use, and it is why dosing in encephalopathy is titrated to stool frequency rather than to a fixed volume.
Nursing considerations before giving it
Confirm the indication before you administer, because it changes what you are titrating to. For constipation, the goal is a comfortable, regular stool. For hepatic encephalopathy, the goal is typically two to three soft stools a day, and the dose is adjusted against that target, not against a set number of millilitres.
Check baseline mental status and ammonia level if the patient has known liver disease, since improvement or deterioration in encephalopathy grade is your best bedside marker of whether the dose is adequate. Review electrolytes before starting, particularly in older or frail patients, since diarrhoea-related losses compound quickly on top of existing hepatic fluid shifts.
What to monitor
Track stool frequency and consistency at every dose, and document it clearly, since this is the parameter the prescriber will use to titrate. In encephalopathy management, also reassess orientation, asterixis, and level of consciousness regularly, comparing against baseline rather than a single snapshot.
Monitor serum sodium and potassium, especially with frequent loose stools, because hypokalaemia and dehydration are the main risks of effective therapy and can themselves worsen hepatic encephalopathy by increasing renal ammonia production. Weigh the patient if losses are significant and monitor for signs of volume depletion such as postural drop or reduced urine output.
Side effects versus adverse effects
Bloating, flatulence, and abdominal cramping are common and expected in the first days of therapy as gut bacteria ferment the sugar; they usually settle and rarely require stopping the drug. A degree of loose stool is also expected and, in encephalopathy dosing, is the intended effect rather than a side effect to correct.
Adverse effects worth escalating are different in character: severe, high-volume watery diarrhoea, signs of dehydration, electrolyte derangement on bloods, or worsening rather than improving confusion despite dosing. Distinguish between the patient who has three soft stools and a clearing sensorium, which is treatment working, and the patient who has eight watery stools and new lethargy, which is over-treatment or a separate problem.
What to hold for and when to call
This is the point most likely to trip you up in practice and on an exam question. Diarrhoea alone is not automatically a reason to hold lactulose when it is being given for hepatic encephalopathy, because soft, frequent stool is the therapeutic endpoint, not a complication. Holding the dose on that basis alone can let ammonia climb and encephalopathy worsen.
Hold and contact the prescriber for suspected bowel obstruction, signs of significant dehydration or electrolyte imbalance, or diarrhoea that is clearly excessive for the dose given, for example more than four or five watery stools when two or three soft ones were the target. Also escalate if the patient's mental status is deteriorating despite adequate stooling, since that suggests another cause needs investigating rather than a lactulose problem.
Patient teaching
Explain that lactulose tastes very sweet and may be more tolerable diluted in water or juice, and that a degree of bloating in the first few days is normal and usually settles. For patients on it long-term for constipation, reinforce that effect can take 24 to 48 hours and dosing should not be doubled out of impatience.
For patients or carers managing hepatic encephalopathy at home, teach them to count and describe stools daily and to treat two to three soft stools as the target, adjusting the dose under guidance rather than stopping it when stools become loose. Make sure they know which changes, worsening confusion, new drowsiness, reduced urine output, warrant a call to the clinical team rather than waiting for the next appointment.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our gastrointestinal practice questions are the closest set to what this page covers.
Common questions
Should I hold lactulose if the patient has diarrhoea?
Not automatically. When lactulose is prescribed for hepatic encephalopathy, soft frequent stools are the intended effect, so mild to moderate diarrhoea is usually expected. Hold and escalate only for excessive, watery diarrhoea, dehydration, or electrolyte disturbance, and clarify the target stool count with the prescriber rather than stopping on your own.
How is the lactulose dose titrated in hepatic encephalopathy?
The dose is adjusted against stool output, aiming for roughly two to three soft stools per day, alongside improvement in mental status. Too little produces no bowel change and no ammonia clearance; too much causes excessive diarrhoea and electrolyte loss, so the dose sits between those two points.
Why does lactulose lower ammonia if it isn't absorbed?
It works locally in the colon. Bacterial fermentation of lactulose acidifies the gut, converting absorbable ammonia into non-absorbable ammonium, which is then excreted in stool. The drug itself never needs to reach the bloodstream to have this effect.
Is lactulose safe for a patient with diabetes?
Lactulose is a sugar-based compound, so blood glucose should be monitored more closely in patients with diabetes, particularly at higher doses. It is still commonly used in this population when clinically indicated, but the prescriber should be aware of the diagnosis when dosing.
Can lactulose be given rectally?
Yes, lactulose enemas are sometimes used in acute or severe hepatic encephalopathy when a patient cannot take oral doses reliably or needs a faster effect. Oral or nasogastric dosing is standard once the patient can tolerate it.